EUVIMEDEUVIMED entdecken
Crossref

Low Prevalence of Carbapenemase Gene NDM-1 in Uropathogenic Klebsiella pneumoniae and Escherichia coli: A Molecular Surveillance Study

Chinaza Maria Ozuluoha, Moses Nkechukwu Ikegbunam, Celestine Emeka Ekwuluo, Kennedy Oberhiri Obohwemu, Kenneth Oshiokhayamhe Iyevhobu, Abba Sadiq Usman, Samuel Sam Danladi, Oladipo Vincent Akinmade, Christabel A. Ovesuor, Aliyou Moustapha Chandini, Jennifer Adaeze Chukwu

The American Journal of Medical Sciences and Pharmaceutical Research · 31.01.2026 · 08 (01) · 96-107

DOI: 10.37547/tajmspr/volume08issue01-14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Medical Sciences and Pharmaceutical Research, online erschienen am 31.01.2026. Verfasst von Chinaza Maria Ozuluoha und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The New Delhi Metallo β lactamase 1 (NDM 1) gene has emerged as a major global health concern because of its ability to confer resistance to β lactam antibiotics, particularly carbapenems. These antibiotics are often considered last line agents, and resistance severely limits treatment options. NDM 1 is frequently associated with urinary tract infections (UTIs) caused by multidrug resistant Gram-negative bacteria, and its spread poses a serious challenge to patient care. Continuous surveillance is therefore essential to track its prevalence and guide effective treatment and prevention strategies.

Aim

This study set out to determine the prevalence of the NDM 1 gene in clinical isolates obtained from patients with UTIs in Onitsha Metropolis.

Methods

Thirty clinical isolates from patients diagnosed with UTIs were analyzed. Genomic DNA was extracted from each isolate, and the presence of the NDM 1 gene was assessed using Polymerase Chain Reaction (PCR). Amplified products were separated on agarose gel electrophoresis and visualized with ethidium bromide staining to confirm gene detection.

Results

Of the thirty isolates examined, only one tested positive for the NDM 1 gene. This finding corresponds to a prevalence rate of 3.33 percent among the studied samples. Although the prevalence was low, the detection of NDM 1 in even a single isolate is significant, given the potential for plasmid mediated dissemination across bacterial populations.

Conclusion

The study demonstrates a low prevalence of NDM 1 among UTI isolates in Onitsha. However, the presence of the gene underscores the importance of ongoing surveillance, strict infection control measures, and antimicrobial stewardship to prevent its wider spread. Larger studies are recommended to provide a more comprehensive understanding of the distribution and clinical impact of NDM 1 in Nigeria and similar settings.

Zitieren

APA

Ozuluoha, C. M., Ikegbunam, M. N., Ekwuluo, C. E., Obohwemu, K. O., Iyevhobu, K. O., Usman, A. S., Danladi, S. S., Akinmade, O. V., Ovesuor, C. A., Chandini, A. M., & Chukwu, J. A. (2026). Low Prevalence of Carbapenemase Gene NDM-1 in Uropathogenic Klebsiella pneumoniae and Escherichia coli: A Molecular Surveillance Study. The American Journal of Medical Sciences and Pharmaceutical Research, 08(01), 96-107. https://doi.org/10.37547/tajmspr/volume08issue01-14

Vancouver

Ozuluoha CM, Ikegbunam MN, Ekwuluo CE, Obohwemu KO, Iyevhobu KO, Usman AS, et al. Low Prevalence of Carbapenemase Gene NDM-1 in Uropathogenic Klebsiella pneumoniae and Escherichia coli: A Molecular Surveillance Study. The American Journal of Medical Sciences and Pharmaceutical Research. 2026;08(01):96-107. doi:10.37547/tajmspr/volume08issue01-14

BibTeX
@article{Ozuluoha2026,
  author = {Ozuluoha, Chinaza Maria and Ikegbunam, Moses Nkechukwu and Ekwuluo, Celestine Emeka and Obohwemu, Kennedy Oberhiri and Iyevhobu, Kenneth Oshiokhayamhe and Usman, Abba Sadiq and Danladi, Samuel Sam and Akinmade, Oladipo Vincent and Ovesuor, Christabel A. and Chandini, Aliyou Moustapha and Chukwu, Jennifer Adaeze},
  title = {Low Prevalence of Carbapenemase Gene NDM-1 in Uropathogenic Klebsiella pneumoniae and Escherichia coli: A Molecular Surveillance Study},
  journal = {The American Journal of Medical Sciences and Pharmaceutical Research},
  year = {2026},
  volume = {08},
  number = {01},
  pages = {96--107},
  doi = {10.37547/tajmspr/volume08issue01-14}
}
Kostenlos starten →